Komori
Governance4519CHUGAI PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Matters Concerning Controlling Shareholders

Roche Holding Ltd. is the parent company, holding 61.12% of the Company's voting rights. The report also describes the Company's relationship with its parent company and its framework for protecting minority shareholders. No specific changes from the previous report are indicated in this document.

Worth reading
59In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
61.12
Voting rights ownership ratio (%)
Wording
Definitive
How definitive the wording is.

Governance structure

Controlling shareholder
Roche Holding Ltd.61.12%Voting rights

parent company), voting rights ownership ratio of 61.12%

When one company holds most of the voting rights, its wishes are more likely to prevail in management. How the interests of minority shareholders are protected is a key issue.

Number of directors9 directors, including Not disclosed outside directors
Number of independent officers3Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Committee3
Nomination Committee: outside members account for half of the committeeand the chair is an independent outside director. Special Committee: composed solely of independent outside directors and outside Audit & Supervisory Board membersrepresenting 100% of the committee. The Remuneration Committee is not disclosed.
Changes this time

Changes from the previous report: Not disclosed

Governance structure
ItemDetails
Number of directors9 directors, including Not disclosed outside directors
Number of independent officers3
CommitteeNomination Committee: outside members account for half of the committee, and the chair is an independent outside director. Special Committee: composed solely of independent outside directors and outside Audit & Supervisory Board members, representing 100% of the committee. The Remuneration Committee is not disclosed.
Controlling shareholderRoche Holding Ltd. (parent company), voting rights ownership ratio of 61.12%
Changes this timeChanges from the previous report: Not disclosed
Items this document does not state (3)
Corporate Governance StructurePolicy on cross-shareholdingsTakeover defenses

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To disclose the Company's relationship with its controlling shareholder, etc., the details of its strategic alliance, the independence of its management, and the status of measures to protect minority shareholders.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Matters Concerning Controlling Shareholders | CHUGAI PHARMACEUTICAL CO.,LTD. (4519) timely disclosure | Komori